However, the outcome of four of the included studies was prostate cancer risk or urological outcomes [17, 22, 23, 29], thus any reported ethnic differences in PSA values from the patient characteristics of these studies should have been free from publication bias. This evidence concerns the gene KLK3 and prostate carcinoma.